Skip to main content
. 2016 Feb 22;47(3):798–806. doi: 10.1161/STROKEAHA.115.012360

Table 1.

Patient and Procedural Characteristics for the Four Trials: SWIFT PRIME, ESCAPE, EXTEND-IA, and REVASCAT

graphic file with name str-47-798-g001.jpg